EUR 2.38
(4.39%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 12.55 Million EUR | -0.12% |
2022 | 12.56 Million EUR | 8.51% |
2021 | 11.58 Million EUR | 12.19% |
2020 | 10.32 Million EUR | 8.06% |
2019 | 9.55 Million EUR | 99.93% |
2018 | 4.77 Million EUR | 37.59% |
2017 | 3.47 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 12.54 Million EUR | 0.0% |
2023 Q4 | 12.55 Million EUR | 0.0% |
2023 Q2 | 12.37 Million EUR | 0.0% |
2023 FY | 12.55 Million EUR | -0.12% |
2022 Q2 | 11.91 Million EUR | 0.0% |
2022 Q4 | 12.56 Million EUR | 0.0% |
2022 FY | 12.56 Million EUR | 8.51% |
2021 Q4 | 11.58 Million EUR | 0.0% |
2021 FY | 11.58 Million EUR | 12.19% |
2021 Q2 | 10.89 Million EUR | 0.0% |
2020 Q2 | 9.99 Million EUR | 0.0% |
2020 Q4 | 10.32 Million EUR | 0.0% |
2020 FY | 10.32 Million EUR | 8.06% |
2019 Q2 | 5.13 Million EUR | 0.0% |
2019 Q4 | 9.55 Million EUR | 0.0% |
2019 FY | 9.55 Million EUR | 99.93% |
2019 Q3 | 9.55 Million EUR | 86.04% |
2018 Q4 | 4.77 Million EUR | 0.0% |
2018 FY | 4.77 Million EUR | 37.59% |
2017 FY | 3.47 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Philogen S.p.A. | 119.27 Million EUR | 89.474% |
Ulisse Biomed S.p.A. | 32.04 Million EUR | 60.826% |